Skip to main content

Information on the use of Mounjaro (Tirzepatide) for weight management

Tirzepatide (Mounjaro) is a weight loss drug that was approved by the National Institute for Health and Care and Excellence (NICE) in the UK on 23 December 2024.

Please visit www.nhsglos.nhs.uk/your-health-services/healthy-communities/weight-loss-medication/ for more information.

Prescription turnaround times

May 1st 2024: repeat prescriptions will now take 5 working days to process.